Get involved. Stay informed.

Principled Decision-Making

Interview and Reception

Wednesday, March 29, 4-6:00pm

Tyler Shultz’s gutsy decision to blow the whistle on Theranos ten years ago had major consequences for the company and its founders. It also resulted in increased scrutiny of the medtech startup space and exacted a huge personal cost.

What does Tyler believe today given the perspective of time? Was doing the right thing worth it?  What is next for him as a founder? Please join us for one-on-one conversation with Fogarty Innovation CEO Andrew Cleeland on Principled Decision-Making.

This is a hybrid event. Email Fogarty Education to inquire about in-person or zoom attendance.

Designing and Implementing a

Quality Management System

Tuesday, April 4, 12 -1:30pm

Why does a quality management system (QMS) matter? What is the best way to approach considering and implementing one? How do you figure out the appropriate level of complexity for your company stage, and how will you know when to change or upgrade?

Don’t miss this opportunity to learn everything you need to know about designing and implementing a QMS from Grace Li,  VP Quality and Regulatory at Enspectra Health. This is an in-person event.

Email Fogarty Education to register.

The Impact of Changing IP Policy

Monday, April 10, 5:30 – 6:30 pm PT

Join the Stanford Biodesign Policy Program and the Council for Innovation Promotion for a roundtable discussion on critical issues in IP law and policy, including the extent to which medical devices and diagnostics are eligible for patent protection, how much patent validity can be challenged after patents are granted, and whether patent rights should be limited for vaccines or critical therapies. The impact of these policy decisions could shape innovation for the foreseeable future.

From the Innovator’s Workbench –

K. Angela Macfarlane

Wednesday, April 19, 6 – 7pm

Join Stanford Biodesign for a lively evening with
K. Angela Macfarlane! In a candid interivew with Lyn Denend, Biodesign director of academic programs, Angela will share lessons from her remarkable career with a special focus on how she has cultivated her unique leadership style.

Angela is the CEO of Perceive Biotherapeutics, managing member of ForSight Labs, and a board member of Fogarty Innovation.